AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Radiation improves survival in node-positive breast cancer patients.

Women's Health Weekly

| June 03, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 JUN 3 - (NewsRx.com & NewsRx.net) -- Postmastectomy radiotherapy improves overall survival in node-positive breast cancer patients.

"Postmastectomy irradiation substantially reduces the risk of locoregional recurrences (LRR) of breast carcinoma. However, debates continue on the prognostic factors for radiotherapy and the effect of radiotherapy on overall survival. The present study was undertaken to investigate the prognostic significance of level III positive nodes, along with the other factors for LRR, and to evaluate the effect of postmastectomy radiotherapy on overall survival among node-positive breast carcinoma treated systemically," scientists in Turkey report.

"Data from 549 consecutive node-positive breast cancer patients who underwent modified radical mastectomy and received adjuvant systemic therapy were studied retrospectively," said Bekir Kuru and colleagues at the Ankara Oncology Education and Research Hospital. "Prognostic factors for LRR and the effect of postmastectomy radiotherapy on overall survival were analyzed. Survival curves were generated by the Kaplan-Meier method, and multivariate analysis was performed by the Cox proportional hazard model. The 5-year locoregional recurrence rate is 7%. Apical invasion was found to be an independent prognostic factor for LRR ...

Related articles from newspapers, magazines, journals, and more
ARIAD Announces Start of Phase 2 Clinical Trial of Oral Deforolimus in Patients...
Press release article from: Business Wire July 30, 2008 700+ words
...with metastatic, HER2-positive breast cancer who have developed resistance...United States. HER2-positive breast cancer is a breast cancer that...of cancer -- not only breast cancer. HER2-positive breast cancers tend to be more...
Herceptin Improves Survival for the First Time in Women With Early-Stage...
Newspaper article from: PR Newswire Europe April 26, 2005 700+ words
...with early-stage HER2-positive breast cancer. These results provide...in early-stage HER2-positive breast cancer suggest that Herceptin may...in early-stage HER2-positive breast cancer. The news of these North...
MammaPrint(R) Breast Cancer Test Validated in Lymph Node-Positive Breast Cancer...
Press release article from: PR Newswire December 13, 2007 700+ words
...power of its MammaPrint(R) breast cancer prognosis test in patients...risk group of lymph node-positive breast cancer patients with an excellent...disease outcome in lymph node positive breast cancer patients," said Prof. Dr...
Genomic Health, Inc. Announces Positive Results from First Study Using Oncotype...
Press release article from: PR Newswire June 3, 2007 700+ words
...Chemotherapy Benefit in Node-Positive Breast Cancer Patients Recommendation...node negative or node-positive breast cancer, all of whom were treated...with hormone receptor-positive breast cancer, regardless of whether...
Interim Analysis of Phase III Study Shows TAXOTERE(R) (docetaxel)-Based...
Press release article from: PR Newswire September 15, 2005 700+ words
...with early stage HER2-positive breast cancer EDMONTON, Alberta and BRIDGEWATER...factor receptor 2 (HER2)-positive breast cancer. The BCIRG 006 trial compared...for over 25 years. HER2-positive breast cancer first described in 1987...
Herceptin given prior to surgery improves the chance of survival without...
News wire article from: Chemical Business Newsbase December 11, 2008 700+ words
...locally advanced HER2-positive breast cancer were free of their disease...locally advanced HER2-positive breast cancer. The results of this study...advanced (metastatic) HER2-positive breast cancer. Herceptin received approval...
Data Suggest Femara(R) (letrozole tablets) More Effective Than Tamoxifen In...
Press release article from: PR Newswire December 10, 2001 700+ words
...with ER and HER-2 positive breast cancer, according to findings...sensitive advanced breast cancer," said Matthew...Clinical Director, Duke Breast Cancer Program, Duke University...disease -- HER-2 positive breast cancers." Study...
Herceptin Plus Chemotherapy Improved Disease-Free Survival and Overall Survival...
Press release article from: PR Newswire May 13, 2005 700+ words
...factor receptor 2 (HER2)-positive breast cancer patients receiving Herceptin...delay early-stage HER2-positive breast cancer from relapsing," said...associated lymph nodes) HER2-positive breast cancer received Herceptin plus...
Updated Overall Survival Data From Pivotal Herceptin Adjuvant Studies in...
Press release article from: Business Wire June 4, 2007 700+ words
...in Patients with HER2-positive Breast Cancer CHICAGO -- Genentech...adjuvant treatment of HER2-positive breast cancer. Data presented at the...HER2-positive, node-positive breast cancer, compared to patients who...
Independent Nurse: Clinical - Advances in breast cancer treatment.(Aromatase...
Magazine article from: GP November 10, 2006 700+ words
...recurrence in women with early stage breast cancer. Two of the trials were stopped...chemotherapy for early stage breast cancer. Participants have been divided...survival for women with HER-2 positive breast cancer (52 per cent decrease in disease...
For more facts and information, see all results

Source: HighBeam Research, Radiation improves survival in node-positive breast cancer patients.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA